Karan Johar India Entertainment audience vaccines CEO security Manufacturing pharmaceuticals Karan Johar India

Karan Johar’s Dharma Productions Secures Major Investment From Pharmaceutical Tycoon Adar Poonawalla

Reading now: 323
variety.com

Naman Ramachandran Pharmaceutical tycoon Adar Poonawalla’s Serene Productions is investing $119 million in Indian media personality Karan Johar‘s Dharma Productions and Dharmatic Entertainment.

The deal values Dharma at $238 million and gives Serene Productions a 50% stake in the company. Under the new structure, Johar will retain 50% ownership and serve as executive chair, overseeing the creative direction.

Apoorva Mehta will continue as CEO, managing strategic and operational aspects of the business. The partnership aims to leverage Dharma’s storytelling expertise with Poonawalla’s business acumen to expand into large-scale, multi-lingual productions, build franchises, and enhance traditional entertainment formats.

The companies plan to focus on creating content for global audiences across various platforms. With revenues of $124 million for the 2022-23 financial year, Dharma is one of the top studios in India.

Read more on variety.com
The website starsalert.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA